معرفی
Professor Robin Shattock is the Head of Mucosal Infection and Immunity within the Department of Medicine at Imperial College London. He leads a team of 26 staff including researchers, PhD students, and project managers. His research focuses on mucosal infection mechanisms and novel vaccine strategies for global health challenges, particularly HIV. He has published over 160 peer-reviewed articles and secured funding from major organizations including the Bill and Melinda Gates Foundation, Wellcome Trust, and EU Framework Programmes.
- Affiliations: Centre for Advanced Therapeutics, Future Vaccine Manufacturing Research Hub, Immuno-Pathology Network, Vaccine Research Network.
- Key Projects: Leads ADITEC (Advanced Immunisation Technologies), BioVacSafe (vaccine safety biomarkers), and EAVI2020 (HIV vaccine development consortium). Coordinates the DNAVAC project under the Collaboration for AIDS Vaccine Discovery (CAVD).
Research interests span DNA vaccination technologies, immune monitoring, and translational vaccine development. His work emphasizes preclinical-to-clinical pipelines for HIV and other infectious diseases.
Grants and collaborations include EU H2020, IMI, and NIH support. Oversee experimental medicine trials for promising HIV vaccine candidates.
Labs/Teams: Directs the Shattock Lab focused on mucosal immunity and vaccine design, collaborating with global networks across 23 institutions.
